As CNS studies become more targeted and precision-based, the ability to effectively tap into the correct patient populations and meet enrollment targets has become a major challenge. These challenges create a major threat to the success of your study, and with a 96% failure rate in CNS studies, you need to make every decision count.
In many cases, potential study subjects with the right clinical profile, history, and typology do not present to traditional research settings; rather, they are deeper and more dispersed in non-research community settings, including community mental health centers, local hospitals, and similar facilities that do not have a built-out research infrastructure.
Given CNS studies require well trained sites, many sponsors struggle to identify, select, and activate sites to meet the demands of the study.
Our teams at WCG's MedAvante-ProPhase and ThreeWire are current working with sponsors to create a CNS Clinical Research Site Blueprint – leveraging:
- Existing high performing investigators identified by our Knowledge Base,
- Location and creation of potential “pop up sites” that can work within community settings,
- Rapid site startup teams that leverage virtual as well as on-site support,
- Deployment of an ePRO / patient engagement service to support homebased/virtual factors.
Visibility and control of the solution is all powered by the Virgil Investigative Research Platform and coupled to virtual access to a global cohort of expert clinicians to ensure diagnostic accuracy, careful vetting, and reliable remote assessments when and where required.
I’d be happy to organize a quick discussion with our SMEs to review your current programs and how our Site Optimization solution can help you to achieve your objectives. When would you be available for such a discussion?